Tuesday, September 22, 2026

$FOUR: Shift4 at 6.5x EBITDA. Is the organic growth real? | Emeth Value Capital

Shift4 trades at 6.5x EBITDA despite 11% reported organic growth, with Shift4 Dine equipment leases cited as evidence of net-new merchant additions.

FOUR $2.9B

Yet Another Value Podcast Sep 22 21 clicks

Sep 22 VSH $5.8B

Analog Semiconductor Smorgasbord, Feat. TXN, ON, VSH

Cestrian Capital Research 6 clicks

Sep 22 FLY $3.9B

Monte Investments Market Brief Vol. CXXVIII

Monte Independent Investment Research 9 clicks

From X

@ACapitalLP Sep 2 1 click

A Capital on X

They did the $GNW math… https://t.co/O8PuFZ6zfo https://t.co/vPm6hw8J7o

@natstewart5 Sep 2 1 click

Nat Stewart on X

$TLYS turnaround looking good: ° Same-store comps +12.1% ° August (first month of Q3) comps +14.6% ° 13 month steak of growth ° Cash + securities $62.2M vs $50.7M ° Q2 net income $8.4M up from $3.2M Gross margin +300 bps Most important, earings I bought my daughter on Tilly's store visit are her fav pair, so wins all around 🥳

@pennycheck Sep 2

⚽️📡 on X

$NTSK absolutely smash print NNARR bounced to $54M + rev growth re-accelerated steller

@ACapitalLP Sep 2 1 click

A Capital on X

This $APTV underperformance is interesting. 🤨 https://t.co/DHfLEh6lkf

@DeepSailCapital Sep 2

Deep Sail Capital on X

$GPRO - Currently zero short borrow at IBKR. Squeezing the shorts.

@DeepSailCapital Sep 2

Deep Sail Capital on X

$GPRO Squeezing here to $1.7/share. Up from $1.3 earlier today. I suspect the M&A caused alot of short sellers to enter the market and the borrow situation could get crazy, similar to $BYND or $BIRD. https://t.co/YgNwMHMLAF

@negligible_cap Sep 2

Negligible Capital on X

*THOMA BRAVO'S PROOFPOINT IS SAID IN TALKS TO ACQUIRE VARONIS $VRNS https://t.co/dQEBQsKgGl

@BlueDuckCap Sep 2

BDC on X

The rheumatologists on the call also confirmed 2 things: 1.) XGN tests are superior in identifying lupus markers vs legacy and 2.) Myositis is critical to rule out early to avoid very serious lung issues. $XGN launches Myositis labs early next year. Confirmed the entire bull case imho.

Cellebrite (CLBT) Management Meeting: The Road Ahead

Cellebrite converts more than 110% of EBITDA into free cash flow and trades at 12.5 times free cash flow, with management targeting 15% or…

CLBT $2.8B

Aurelion Research Sep 22 9 clicks

Meta's Muse Could be Big Win for Innodata

Innodata's new Meta contract for long-horizon agent personalization ties the data company to Meta's Muse AI assistant, despite Meta's Scale…

INOD $2.4B

Hunterbrook Sep 22 12 clicks

Undercovered Dozen: Rithm Capital, Sterling Infrastructure, Corning And More

Undercovered Dozen spotlights 12 lesser-covered stocks, including Rithm Capital, Sterling Infrastructure and Corning.

RITM $5B

The Undercovered Dozen Sep 22

Emeth Value Capital’s Andrew Carreon on Shift4 ($FOUR)

Shift4 trades at 6.5 times EBITDA despite 11% organic growth, with Shift4 Dine equipment leases reaching a $400 million run rate as…

FOUR $2.9B

Yet Another Value Blog Sep 22 4 clicks

Copart's Return To Growth Starts Now: Adair's $1.9B Bet On ACV Auctions

Copart’s $1.9 billion ACV Auctions acquisition targets renewed growth, with EPS accretion expected by fiscal 2028 as insurance…

ACVA $1.8B

Robert J. Lake Sep 22 2 clicks

Quick Value #331 - Corteva / Vylor Spin-Off

Corteva will spin off its Pioneer seed business, Vylor, on October 1, leaving crop protection RemainCo that could trade at 6.5-8.5x 2026…

CTVA $8.4B

Value Don't Lie Sep 21 5 clicks

[CoStar] Homes are different

CoStar spent more than $1 billion building Homes.com to challenge Zillow, betting seller-agent leads, proprietary listing content and…

ZG $6.2B

scuttleblurb Sep 21 4 clicks

ARKO. 3x Owner’s Earnings multiple, 21% ROCE, Founders involved and large shareholders, Stake in a public company>market cap. Superb Capital Allocators

ARKO trades at 3 times estimated 2025 owner’s earnings, while its 73.6% APC stake exceeds its $473 million market cap.

ARKO $453M

Calvin Blissett Sep 21 4 clicks

Bioventus: Cash Flow Anchors The Bull Case Beyond A Potential Sale

Bioventus uses established-product cash flow to cut debt and fund launches, while its 2030 term loan extension and lower margin support its…

BVS $1.1B

Equity Eagle Sep 21

I Tested Three Cannibals Against Dillard’s. I Bought Two. (CROX, CNX, GPI)

Crocs, CNX and Group 1 are tested against Dillard’s buyback-driven share-count reduction, with Group 1 leading and CNX’s convertible notes…

CROX $5.7BCNX $4.7B

Cannibal Stocks Sep 20 2 clicks

TRIP · long

Tripadvisor INC

Tripadvisor (TRIP) is presented as a long idea.

TRIP $985M

Value Investors Club Jun 24 5 clicks

Aggressive Portfolio Trades: Buy Vail Resorts, Buy ORR, Short GEO

Vail Resorts, down 60% since 2022, is pitched for an El Niño-driven ski-season rebound; the portfolio also buys ORR and shorts GEO.

MTN $5.1BGEO $4B

Ian’s Insider Corner Sep 20 9 clicks

🍔New Chapter 11 Bankruptcy Filing - Meritage Hospitality Group Inc.🍔

Meritage Hospitality, a 320-unit Wendy’s franchisee, filed Chapter 11 amid $137 million of bank debt, $391 million of leases and a…

WEN $1.2B

PETITION Sep 20 3 clicks

Bumble, 2x Owner’s Earnings. Sentiment is abysmal, the founder is back. The stock could easily be a multibagger.

Bumble trades at roughly 2x owner’s earnings and 4.76x enterprise value, with Whitney Wolfe Herd’s return central to a rerating case.

BMBL $335M

Calvin Blissett Sep 20 4 clicks

Who Really Runs Crocs? The Autopsy.

Crocs CEO Andrew Rees turned around the core brand, then borrowed $2 billion for HEYDUDE, whose $737 million write-down followed wholesale…

CROX $5.7B

Cannibal Stocks Sep 19 5 clicks

Karman: Why I'm Upgrading To Buy After A 68% Drop

Karman Holdings (KRMN) is upgraded after a 68% drop, with 24% organic growth, a $1.3 billion backlog and higher 2026 guidance offset by…

KRMN $4.3B

Dhierin Bechai Sep 19 1 click

QNT: The 100× Question

Quantinuum's improving logical-qubit error correction, 1,504 successful-circuit benchmark score and paid deployments at RIKEN, BMW and…

QNT $1.9B

Mispriced Assets Sep 18 3 clicks

DeFi Development: The Clarity Act Failure Tests The Solana Treasury Thesis

DeFi Development’s Solana treasury strategy faces dilution, preferred dividends and tight liquidity after a 50% rally, with $4.3 million of…

DFDV $175M

Dorine Cherop Sep 18

Research & Analysis: Ultra Clean Holdings (NASDAQ: UCTT)

Ultra Clean Holdings targets a $4 billion annualized revenue run rate by H2 2027 through manufacturing expansion and a broader…

UCTT $3.5B

Monte Independent Investment Research Sep 18 2 clicks

Anterix: The Spectrum Case Is Real, But The Chart And The Insiders Say Wait

Anterix’s 900 MHz spectrum could be worth $2.5–$7 billion, versus a $1.41 billion enterprise value, but insider selling and lumpy…

ATEX $1.5B

The Market Auditor Sep 18 2 clicks

Tuesday, September 22, 2026

A Capital on X

Nat Stewart on X

⚽️📡 on X

A Capital on X

Deep Sail Capital on X

Deep Sail Capital on X

Negligible Capital on X

BDC on X

Investor Letters

Publications we follow

Newsletters 93

YouTube 4

Blogs 12

Seeking Alpha 42 of 203

X accounts we follow

Investor letters we follow

Sectors